Company intelligence / Profile preview
Bionorica
Neumarkt i.d.OPf., Bavaria, Germanybionorica.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bionorica has a long track record of commercialized phytopharmaceuticals for respiratory, gynecological, urinary tract, and liver conditions. Its lead pipeline programs include a Phase III trial of an herbal extract for primary dysmenorrhea and a Phase III program for dronabinol oral solution targeting spasticity in MS. The company’s marketed products are supported by clinical research demonstrating efficacy and safety.[6][8]
- Therapeutic areas
- GastroenterologyPulmonologyWomen's HealthNeurologyInfectious Diseases
- Modalities
- Plant-based therapeutics (phytopharmaceuticals)Herbal extracts and standardized plant compounds[2][3][7]Synthetic cannabinoids (e.g., dronabinol)[8]
- Industry
- Biotech
02
Drug pipeline
16 assets15 more assets in the full pipeline.
03
Partnerships
ReproCELL
Beyond the preview
Go deeper on Bionorica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bionorica.